Heartflow (NASDAQ:HTFL) Stock Price Down 5.7% – What’s Next?

Heartflow, Inc. (NASDAQ:HTFL) shares were down 5.7% on Tuesday . The company traded as low as $29.00 and last traded at $29.47. Approximately 488,288 shares traded hands during mid-day trading, a decline of 6% from the average daily volume of 521,741 shares. The stock had previously closed at $31.25.

Analysts Set New Price Targets

Several research firms have issued reports on HTFL. Canaccord Genuity Group boosted their price objective on shares of Heartflow from $39.00 to $40.00 and gave the stock a “buy” rating in a research note on Thursday, November 13th. Morgan Stanley assumed coverage on Heartflow in a research note on Tuesday, September 2nd. They set an “equal weight” rating and a $35.00 price objective on the stock. JPMorgan Chase & Co. increased their target price on Heartflow from $36.00 to $40.00 and gave the company an “overweight” rating in a research note on Thursday, November 13th. Piper Sandler began coverage on shares of Heartflow in a research report on Tuesday, September 2nd. They issued an “overweight” rating and a $38.00 price objective for the company. Finally, Stifel Nicolaus boosted their price target on Heartflow from $35.00 to $40.00 and gave the stock a “buy” rating in a research note on Thursday, November 13th. Four analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Heartflow currently has an average rating of “Hold” and a consensus target price of $38.60.

Heartflow Stock Down 2.2%

The business’s 50-day moving average is $31.88.

Heartflow (NASDAQ:HTFL) last issued its quarterly earnings data on Friday, September 19th. The company reported ($1.46) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.20) by ($1.26). The company had revenue of $43.42 million for the quarter, compared to analyst estimates of $43.20 million.

Insider Activity

In other news, Director Jeffrey C. Lightcap acquired 40,000 shares of the company’s stock in a transaction dated Tuesday, December 16th. The shares were bought at an average price of $26.34 per share, with a total value of $1,053,600.00. Following the purchase, the director owned 40,000 shares of the company’s stock, valued at approximately $1,053,600. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Institutional Trading of Heartflow

A number of institutional investors have recently bought and sold shares of HTFL. Hudson Bay Capital Management LP acquired a new position in shares of Heartflow during the 3rd quarter valued at about $288,000. XXEC Inc. acquired a new position in shares of Heartflow in the 3rd quarter worth approximately $1,004,000. Zimmer Partners LP bought a new position in shares of Heartflow during the third quarter valued at $673,000. Alyeska Investment Group L.P. bought a new position in shares of Heartflow in the third quarter worth about $2,861,000. Finally, Summit Partners Public Asset Management LLC bought a new stake in Heartflow during the 3rd quarter worth about $28,559,000.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.